findmyKOL
Clinical trialNCT00090519CompletedPhase 3Interventional

Reduction in the Occurrence of Center-Involved Diabetic Macular Edema

SponsorChromaderm, Inc.Enrollment731Diabetic Retinopathy
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

84 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Parramatta, New South Wales, Australia

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Sydney, New South Wales, Australia

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Westmead, New South Wales, Australia

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Woodville, South Australia, Australia

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Nedlands, Western Australia, Australia

Brazil
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Curitiba, Brazil

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Goiânia, Brazil

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    São Paulo, Brazil

Canada
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Vancouver, British Columbia, Canada

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Halifax, Nova Scotia, Canada

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    London, Ontario, Canada

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Ottawa, Ontario, Canada

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Toronto, Ontario, Canada

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Montreal, Quebec, Canada

Denmark
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Aarhus, Denmark

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Glostrup Municipality, Denmark

France
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Bordeaux, France

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Nantes, France

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Paris, France

Germany
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Leipzig, Germany

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Münster, Germany

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Sulzbach, Germany

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Ulm, Germany

India
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Chennai, India

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Hyderabaad, India

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    New Delhi, India

Italy
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Milan, Italy

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Udine, Italy

Mexico
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Mexico City, Mexico

Netherlands
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Amsterdam, Netherlands

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Rotterdam, Netherlands

Poland
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Bydgoszcz, Poland

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Katowice, Poland

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Lublin, Poland

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Poznan, Poland

Portugal
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Coimbra, Portugal

Russia
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Moscow, Russia

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Saint Petersburg, Russia

Spain
  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Alicante, Spain

  • for Additional Information Regarding Investigative Sites for This Trial, Contact 1-877-Ctlilly (1-877-285-4559, 1-317-615-4559) Mon - Fri From 9 Am To 5 Pm Eastern Time (utc/gmt - 5 Hours, Est), Or Speak With Your Personal Physician.

    Barcelona, Spain

44 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Feb 2004
Primary completion
30 Apr 2010
Completion
30 Apr 2010
Last update posted
6 Oct 2016
Registered enrollment
731
Registry id
NCT00090519

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.